Genetic Technologies Ltd.
N/A
USD
N/A
N/A
...
Chart
Financials
Description
GENE Company Description
Genetic Technologies Ltd is an Australia-based molecular diagnostics company that offers predictive testing and assessment tools to help physicians proactively manage women's health. The company has developed BREVAGenplus which is a clinically validated risk assessment test for non-hereditary breast cancer. It also provides genetic testing services including medical testing, animal testing, forensic testing, and plant testing. The company markets BREVAGenplus to healthcare professionals in breast healthcare and imaging centers, as well as to obstetricians/ gynecologists (OBGYNs) and breast cancer risk assessment specialists. The majority of the company's revenue is generated from Australia and the United States. The group has two operating segments: EasyDNA and GeneType/Corporate.
GENE Stock Smart Score
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?
Sign Up to view GENE Smart Score
Score Breakdown
GENE Company Description
Show More
Genetic Technologies Ltd is an Australia-based molecular diagnostics company that offers predictive testing and assessment tools to help physicians proactively manage women's health. The company has developed BREVAGenplus which is a clinically validated risk assessment test for non-hereditary breast cancer. It also provides genetic testing services including medical testing, animal testing, forensic testing, and plant testing. The company markets BREVAGenplus to healthcare professionals in breast healthcare and imaging centers, as well as to obstetricians/ gynecologists (OBGYNs) and breast cancer risk assessment specialists. The majority of the company's revenue is generated from Australia and the United States. The group has two operating segments: EasyDNA and GeneType/Corporate. Show Less
All
Government
Consumer Interest
SEC Filings
ESG/Other
Recent trades of GENE by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by GENE's directors and management
Government lobbying spending instances
U.S. Patents
New patents grants
Government Contracts
Federal grants, loans, and purchases
Twitter
Followers on GENE's company Twitter account
WallStreetBets
Number of mentions of GENE in WallStreetBets Daily Discussion
GENE News
Recent insights relating to GENE
CNBC Recommendations
Recent picks made for GENE stock on CNBC
Top ETF Holders
ETFs with the largest estimated holdings in GENE
Corporate Flights
Flights by private jets registered to GENE
Our Analysis